BGM Group Ltd. key statistics and ratios
In fiscal 2025, BGM Group Ltd. had return on equity of -9.2% and a net margin of -52.6%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 |
|---|---|---|---|---|---|---|---|---|
| Net margin | 10.3% | 12.8% | 10.1% | 5.5% | 1.7% | −16.7% | −5.7% | −52.6% |
| Return on equity | 29.4% | 31.4% | 22.0% | 7.8% | 2.0% | −16.2% | −3.4% | −9.2% |
| Return on assets | — | 16.8% | 12.1% | 5.1% | 1.5% | −13.4% | −2.8% | −8.2% |
| Effective tax rate | 15.3% | 14.9% | 14.9% | 7.6% | 12.5% | — | — | — |
| R&D as % of revenue | — | 0.1% | 0.1% | 0.0% | 1.9% | 1.2% | 5.4% | 1.8% |
| SG&A as % of revenue | 4.3% | 7.6% | 5.5% | 5.7% | 6.4% | 8.2% | 13.2% | 48.1% |
| Dividends ÷ net income | 14.1% | — | — | — | — | — | — | — |
Financial health
- Short-term assets cover short-term liabilities $52m of assets due within a year against $42m of liabilities due within a year.
- Short-term assets cover long-term liabilities $52m short-term assets against $319,465 of longer-dated liabilities.
- More cash than debt Cash or debt not separately reported. Not assessable.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
- Operating profit covers interest at least five times over Interest not separately reported. Not assessable.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Compare with peers
- IM Cannabis Corp. statistics
- Cumberland Pharmaceuticals Inc statistics
- Sunshine Biopharma Inc. statistics
- Scilex Holding Co statistics
- Biofrontera Inc. statistics
Head to head: BGM vs IMCCBGM vs CPIXBGM vs SBFM
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies